haloperidol has been researched along with 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Garneau-Tsodikova, S; Garzan, A; Green, KD; Holbrook, SYL; Hou, C; Krieger, K; Pang, AH; Parish, T; Posey, JE; Punetha, A; Thamban Chandrika, N; Tsodikov, OV; Willby, MJ | 1 |
| Brand, L; Castagnoli, N; Oliver, DW; Pond, SM; van der Schyf, CJ | 1 |
| Bergh, JJ; Castagnoli, N; Mienie, LJ; Pond, SM; Steyn, SJ; Van der Schyf, CJ; Van Staden, E | 1 |
| Castagnoli, N; Dormehl, IC; Hugo, N; Keeve, R; Müller-Gärtner, HW; Neumeyer, JL; Oliver, DW; Rossouw, NT; Van der Schyf, CJ | 1 |
| Cartwright, H; Castagnoli, N; Halliday, GM; McRitchie, DA; Pond, SM; Van der Schyf, CJ | 1 |
| Bergh, JJ; Bloomquist, JR; Castagnoli, N; Mienie, LJ; Steyn, SJ; Van der Schyf, CJ | 1 |
| Eyles, DW; Halliday, GM; Pond, SM; Van der Schyf, CJ | 1 |
| Bergh, JJ; Castagnoli, N; Mienie, LJ; Petzer, JP; Van der Schyf, CJ | 1 |
8 other study(ies) available for haloperidol and 4(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from
Topics: | 2021 |
Dopamine receptor binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)- 4-oxobutyl]-1,2,3,6-tetrahydropyridine (HPTP), an intermediate metabolite of haloperidol.
Topics: Animals; Antipsychotic Agents; Benzazepines; Binding, Competitive; Haloperidol; Male; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Spiperone; Tritium | 1996 |
Metabolic defects caused by treatment with the tetrahydropyridine analog of haloperidol (HPTP), in baboons.
Topics: Animals; Dicarboxylic Acids; Electron-Transferring Flavoproteins; Fatty Acid Desaturases; Flavoproteins; Glutarates; Glycine; Haloperidol; Humans; Iron-Sulfur Proteins; Kinetics; Male; Mitochondria; Multienzyme Complexes; Oxidoreductases Acting on CH-NH Group Donors; Oxygen Consumption; Papio | 1997 |
Effect of the haloperidol tetrahydropyridine metabolite 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6- tetrahydropyridine on dopamine receptor and transporter binding. A nonhuman primate 123I-iodobenzamide and 2 beta-carbomethoxy-3 beta-(4-
Topics: Animals; Antipsychotic Agents; Benzamides; Brain; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Haloperidol; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Papio; Pyrrolidines; Receptors, Dopamine; Tomography, Emission-Computed, Single-Photon | 1997 |
Clinical and neuropathological abnormalities in baboons treated with HPTP, the tetrahydropyridine analog of haloperidol.
Topics: Animals; Antipsychotic Agents; Dyskinesia, Drug-Induced; Facial Muscles; Haloperidol; Hypothalamus; Male; Neurons; Papio; Prosencephalon | 1999 |
p-Fluorophenylglycine in the urine of baboons treated with HPTP, the tetrahydropyridine analog of haloperidol.
Topics: Animals; Antipsychotic Agents; Dopamine; Glycine; Haloperidol; Humans; Male; Mice; Oxidation-Reduction; Papio; Propionates | 1999 |
Mitochondrial ultrastructure and density in a primate model of persistent tardive dyskinesia.
Topics: Animals; Antipsychotic Agents; Basal Ganglia; Caudate Nucleus; Dyskinesia, Drug-Induced; Haloperidol; Male; Mitochondria; Neuroglia; Neurons; Neuropil; Papio; Putamen | 2000 |
Metabolic defects caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and by HPTP (the tetrahydropyridinyl analog of haloperidol), in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antipsychotic Agents; Haloperidol; Lactic Acid; Male; Metabolism, Inborn Errors; Mitochondria; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Valerates | 2000 |